3utz
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
==About this Structure== | ==About this Structure== | ||
| - | [[3utz]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | [[3utz]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3UTZ OCA]. |
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:022198278</ref><references group="xtra"/><references/> | <ref group="xtra">PMID:022198278</ref><references group="xtra"/><references/> | ||
| - | [[Category: | + | [[Category: Lk3 transgenic mice]] |
[[Category: Arad-Yellin, R.]] | [[Category: Arad-Yellin, R.]] | ||
[[Category: Brenner, O.]] | [[Category: Brenner, O.]] | ||
Revision as of 06:48, 26 March 2014
Endogenous-like inhibitory antibodies targeting activated metalloproteinase motifs show therapeutic potential
Template:ABSTRACT PUBMED 22198278
About this Structure
3utz is a 6 chain structure with sequence from Lk3 transgenic mice. Full crystallographic information is available from OCA.
Reference
- Sela-Passwell N, Kikkeri R, Dym O, Rozenberg H, Margalit R, Arad-Yellin R, Eisenstein M, Brenner O, Shoham T, Danon T, Shanzer A, Sagi I. Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential. Nat Med. 2011 Dec 25;18(1):143-7. doi: 10.1038/nm.2582. PMID:22198278 doi:10.1038/nm.2582
Categories: Lk3 transgenic mice | Arad-Yellin, R. | Brenner, O. | Danon, T. | Dym, O. | Eisenstein, M. | ISPC, Israel Structural Proteomics Center. | Kikkeri, R | Margalit, R | Rozenberg, H | Sagi, I. | Sela-Passwell, N. | Shanzer, A. | Shoham, T. | Fab domain | Immune system | ISPC | Israel Structural Proteomics Center | Structural genomic
